D. Genre

发表

Patients' regrets after participating in a randomized controlled trials depended on their involvement in the decision making.

P. Viens, J. Mancini, C. Tarpin, 2012, Journal of clinical epidemiology.

Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.

A. Monnier, C. Tarpin, F. Dalenc, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Participants’ uptake of clinical trial results: a randomised experiment

P. Viens, J. Mancini, C. Tarpin, 2010, British Journal of Cancer.

Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy

P. Viens, C. Protière, D. Maraninchi, 2002, Supportive Care in Cancer.

Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care.

P. Viens, G. Gravis, D. Maraninchi, 1997, British Journal of Cancer.

Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma

P. Viens, J. Moatti, G. Gravis, 1999, Cancer.

[Adjuvant chemotherapy with mitoxantrone, cyclophosphamide and 5-fluorouracil in breast neoplasms: therapeutic life].

D. Cowen, P. Viens, D. Maraninchi, 1997, Bulletin du cancer.

Transient detection of β-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy

D. Blaise, P. Viens, G. Gravis, 2002 .

Decision-making and breast cancer clinical trials: how experience challenges attitudes.

A. Monnier, J. Mancini, C. Tarpin, 2007, Contemporary clinical trials.

Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France

P. Viens, C. Protière, A. Gonçalves, 2017, Medical decision making : an international journal of the Society for Medical Decision Making.

Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study

F. Bertucci, P. Viens, G. Gravis, 2002, Bone Marrow Transplantation.

"They should take time": disclosure of clinical trial results as part of a social relationship.

J. Mancini, C. Julian‐Reynier, A. Desclaux, 2012, Social science & medicine.

Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles

P. Viens, G. Gravis, C. Protière, 2002, Supportive Care in Cancer.

High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer

F. Bertucci, D. Cowen, P. Viens, 1997, Bone Marrow Transplantation.

Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy

F. Bertucci, P. Viens, C. Arnoulet, 2003, Bone Marrow Transplantation.

Transparency in the presentation of trial results may not increase patients’ trust in medical researchers

P. Viens, J. Mancini, Anne-Laure Martin, 2012, Clinical trials.

Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens

F. Bertucci, P. Viens, C. Chabannon, 2002, Bone Marrow Transplantation.

Phase I and pharmacokinetic study of escalating dose of docetaxel administered with granulocyte colony-stimulating factor support in adult advanced solid tumors.

P. Viens, G. Gravis, J. Ciccolini, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Weekly administration of docetaxel for symptomatic metastatic hormone‐refractory prostate carcinoma

G. Serment, F. Bladou, V. Bardou, 2003, Cancer.

Docetaxel and Radiotherapy and Pancreatic Cancer

M. Ychou, P. Viens, G. Gravis, 2003, Pancreas.

Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

D. Blaise, P. Viens, N. Vey, 2003, Leukemia.

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.

B. Esterni, P. Viens, R. Largillier, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

B. Esterni, D. Blaise, M. Mohty, 2012, Bone Marrow Transplantation.

A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design

J. Delpero, J. Tuech, J. Boher, 2017, BMC Cancer.

Nurses' Repeat Measurement of Chemotherapy Symptoms: Feasibility, Resulting Information, Patient Satisfaction

P. Viens, D. Maraninchi, A. Braud, 2003, Cancer nursing.

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.

B. Esterni, P. Viens, R. Largillier, 2012 .

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

F. Bertucci, J. Pierga, P. Viens, 2019, Journal of clinical medicine.

Full access to medical records does not modify anxiety in cancer patients

P. Viens, D. Coso, G. Gravis, 2011, Cancer.

Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancer.

F. Bertucci, D. Cowen, P. Viens, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

J. Delpero, J. Tuech, J. Boher, 2017, BMC Cancer.

Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors.

P. Viens, G. Gravis, C. Tarpin, 2003, Anticancer research.

Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.

F. Bertucci, P. Viens, G. Gravis, 2001, Anticancer research.